Defining the risk of SARS-CoV-2 variants on immune protection
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …
variants jeopardizes the protective antiviral immunity induced after infection or …
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
The recent emergence of B.1.1.529, the Omicron variant 1 , 2 , has raised concerns of
escape from protection by vaccines and therapeutic antibodies. A key test for potential …
escape from protection by vaccines and therapeutic antibodies. A key test for potential …
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rapidly emerging SARS-CoV-2 variants jeopardize antibody-based countermeasures.
Although cell culture experiments have demonstrated a loss of potency of several anti-spike …
Although cell culture experiments have demonstrated a loss of potency of several anti-spike …
[PDF][PDF] Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
…, RE Sutton, RH Carnahan, TL Darling, ACM Boon… - Cell, 2021 - cell.com
SARS-CoV-2 has caused the global COVID-19 pandemic. Although passively delivered
neutralizing antibodies against SARS-CoV-2 show promise in clinical trials, their mechanism of …
neutralizing antibodies against SARS-CoV-2 show promise in clinical trials, their mechanism of …
The microbial metabolite desaminotyrosine protects from influenza through type I interferon
…, MN Artyomov, DJ Morales, MJ Holtzman, ACM Boon… - Science, 2017 - science.org
The microbiota is known to modulate the host response to influenza infection through as-yet-unclear
mechanisms. We hypothesized that components of the microbiota exert effects …
mechanisms. We hypothesized that components of the microbiota exert effects …
Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm
…, NJ Anand, DA Striker, RS Martin, ACM Boon… - Science …, 2020 - science.org
We pursued a study of immune responses in coronavirus disease 2019 (COVID-19) and
influenza patients. Compared to patients with influenza, patients with COVID-19 exhibited …
influenza patients. Compared to patients with influenza, patients with COVID-19 exhibited …
[PDF][PDF] A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
The development of an effective vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a …
coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), is a …
Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice
ACM Boon, J DeBeauchamp, A Hollmann… - Journal of …, 2009 - Am Soc Microbiol
Despite the prevalence of H5N1 influenza viruses in global avian populations, comparatively
few cases have been diagnosed in humans. Although viral factors almost certainly play a …
few cases have been diagnosed in humans. Although viral factors almost certainly play a …
[PDF][PDF] Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens
…, E Sane, LA Fischer, D Kumar, L Ma, ACM Boon… - Cell Stem Cell, 2022 - cell.com
Trophoblast organoids derived from placental villi provide a 3D model system of human
placental development, but access to first-trimester tissues is limited. Here, we report that …
placental development, but access to first-trimester tissues is limited. Here, we report that …